156 related articles for article (PubMed ID: 3902267)
41. High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast. A phase III study of the Piedmont Oncology Association (POA).
Zekan PJ; Muss HB; Capizzi RL; Cooper MR; Harding RW; Hopkins JO; Jackson DV; Ramseur WL; Richards F; Spurr CL
Cancer; 1984 Dec; 54(11):2338-43. PubMed ID: 6388802
[TBL] [Abstract][Full Text] [Related]
42. [Therapeutic results and toxic side effects of the combination cytostasan, adriamycin and vincristine as second-line therapy of metastatic breast cancer].
Brockmann B; Kirchhof I; Geschke E; Schmidt UM
Arch Geschwulstforsch; 1989; 59(5):341-6. PubMed ID: 2589933
[TBL] [Abstract][Full Text] [Related]
43. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
Aisner J; Cirrincione C; Perloff M; Perry M; Budman D; Abrams J; Panasci L; Muss H; Citron M; Holland J
J Clin Oncol; 1995 Jun; 13(6):1443-52. PubMed ID: 7751891
[TBL] [Abstract][Full Text] [Related]
44. Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer.
Mulder NH; Mulder PO; Sleijfer DT; Willemse PH; van der Ploeg E; Dolsma WV; de Vries EG
Eur J Cancer; 1993; 29A(5):668-71. PubMed ID: 8471323
[TBL] [Abstract][Full Text] [Related]
45. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
[TBL] [Abstract][Full Text] [Related]
46. Multiple drug intensification after cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF) induction in metastatic breast cancer: a Southeastern Cancer Study Group phase II trial.
Vogel CL; Raney M; Carpenter J
Cancer Treat Rep; 1987 Dec; 71(12):1271-3. PubMed ID: 3690536
[No Abstract] [Full Text] [Related]
47. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.
Fisher B; Dignam J; Mamounas EP; Costantino JP; Wickerham DL; Redmond C; Wolmark N; Dimitrov NV; Bowman DM; Glass AG; Atkins JN; Abramson N; Sutherland CM; Aron BS; Margolese RG
J Clin Oncol; 1996 Jul; 14(7):1982-92. PubMed ID: 8683228
[TBL] [Abstract][Full Text] [Related]
48. Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate.
Aboud A; Buzdar AU; Yap HY; Hortobagyi GN; Blumenschein GR
J Surg Oncol; 1984 Jul; 26(3):205-7. PubMed ID: 6610802
[TBL] [Abstract][Full Text] [Related]
49. Escalating doses of sequential methotrexate and 5-fluorouracil, doxorubicin, and vincristine for the treatment of metastatic breast cancer.
Spitzer TR; Goldsmith GH; Lazarus HM; Kellermeyer RW
Am J Clin Oncol; 1987 Dec; 10(6):483-4. PubMed ID: 3687833
[TBL] [Abstract][Full Text] [Related]
50. Combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in advanced breast carcinoma.
Dalley DN; Levi JA; Aroney RS
Med J Aust; 1980 Mar; 1(5):216-8. PubMed ID: 6990214
[TBL] [Abstract][Full Text] [Related]
51. Use of mitoxantrone-based combination chemotherapy regimens as first-line treatment for advanced breast cancer.
Bezwoda WR; Hesdorffer CS; Dansey RD
S Afr Med J; 1987 Oct; 72(7):465-7. PubMed ID: 3660150
[TBL] [Abstract][Full Text] [Related]
52. Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy.
Rouëssé J; Friedman S; Sarrazin D; Mouriesse H; Le Chevalier T; Arriagada R; Spielmann M; Papacharalambous A; May-Levin F
J Clin Oncol; 1986 Dec; 4(12):1765-71. PubMed ID: 3783202
[TBL] [Abstract][Full Text] [Related]
53. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone.
Tannir N; Yap HY; Hortobagyi GH; Hug V; Buzdar AU; Blumenschein GR
Cancer Treat Rep; 1984; 68(7-8):1039-41. PubMed ID: 6547638
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
55. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
[TBL] [Abstract][Full Text] [Related]
56. [Use of "split" courses of combination chemotherapy in breast cancer].
Dymarskiĭ LIu; Aleksandrova GI; Sanchakova AV
Vopr Onkol; 1981; 27(7):82-5. PubMed ID: 7269435
[TBL] [Abstract][Full Text] [Related]
57. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846
[TBL] [Abstract][Full Text] [Related]
58. Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
Tranum BL; McDonald B; Thigpen T; Vaughn C; Wilson H; Maloney T; Costanzi J; Bickers J; el Mawli NG; Palmer R; Hoogstraten B; Heilburn L; Rasmusen S
Cancer; 1982 Mar; 49(5):835-9. PubMed ID: 7037152
[No Abstract] [Full Text] [Related]
59. cis-platinum-based alternating non-cross-resistant chemotherapy as a first-line treatment in metastatic breast cancer. A phase II study.
Kolarić K; Tomek R
Tumori; 1990 Oct; 76(5):472-5. PubMed ID: 2256193
[TBL] [Abstract][Full Text] [Related]
60. Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio.
Legha SS; Ajani JA; Blumenschein GR; Hortobagyi GN; Buzdar AU
Cancer; 1984 May; 53(9):1836-40. PubMed ID: 6231092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
